PATENT CLAIM ANALYSIS

Application Number: 16071263
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["544", "392000"]

Abstract:
The present invention provides novel polymorphic forms of vortioxetine hydrobromide (I).

Claim (Index 18):
A process for preparation of crystalline Form R2 of Vortioxetine hydrobromide tert-butanol solvate according to  claim 11 , comprising the steps of:\n (a) providing a suspension of Vortioxetine free base in tert-butanol or mixture of solvent containing tert-butanol (b) adding hydrobromic acid to the above suspension and (c) isolating the resulting solid.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15304929', '15048868', '15854458', '14429388', '14902326']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7686767573081761
- 35 USC 102 Novelty (BERT): 0.5421170855610201
- Combined Prediction Score: 0.7460207901334606
- Mean Citation Score: 354.065906
- Max Citation Score: 389.72733
- Similarity Product: 306.46236930895327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test